masennukseen neuroleptejä?

Neuroleptit vahingoittaa aivoja vakavasti mm. tuhoten älykkyyttä ja tunne-elämää. Jos on epäilystä kakssuuntasesta, niin vaadi, että kokeillaan vaikka edes epilepsialääkkeitä mieluummin. Ja muista, et jos et oo pakkohoidos, kukaan ei sua voi käskee syömään mitään.

Todella vastuutonta psykiatrilta määrätä neuroleptejä muille kuin psykooseista kärsiville 1-bipoille ja skitsofreenikoille! Mulle tuli 2-bipodiagnoosi aika äkkiä kun yks SNRI-lääke pisti mut levottomaksi ja ärtyisäksi.

Kyllä ketiapiinia tyrkytetään urakalla, mut se on kuulemma melkoinen kemiallinen lobotomialääke. Syönkin siis melatoniinia 3 mg enkä enää koske ketiapiiniin, kun kuulin sen vaaroista. Se voi tuhota aivojen unensaannista huolehtivan osan ja aiheuttaa aivomassan pienenemistä sekä roima painonnousu voi laukaista diabeteksen. En onneksi syöny kuin max 75 mg yhdessä vaiheessa.

Pitää olla luja psykiatrien kanssa ja taistella oikeuksistaan, mutta vaikeasti masentunut jaksaa tuskin taistella noiden myrkkyjen tuputusta vastaan. Monet psykiatrit ei ole rehellisiä potilaille neuroleptien pahoista sivuvaikutuksista, kun ei monet sitten söisi noita kalliita myrkkyjä -> jää lääkefirmalta saatavat provikat saamatta kallonkutistajalta.

Miksei psykoterapia ja keskusteluapu ole ensisijainen vaihtoehto tällaisissa tapauksissa?

Simple Truths About Psychiatry - Episode 6: Psychiatric Drugs Are More Dangerous than You Ever Imagined (Nov 4, 2014)
http://www.youtube.com/watch?v=luKsQaj0hzs

"Dr. Breggin's background includes Harvard College, Case Western Reserve Medical School, a one-year internship and a three-year residency in psychiatry, including a teaching fellowship at Harvard Medical School. After his training, he accepted a two-year staff appointment at the National Institute of Mental Health (NIMH). He has taught at several universities, including a faculty appointment to the Johns Hopkins University Department of Counseling and an appointment as Visiting Scholar at SUNY Oswego in the Department of Counseling and Psychological Services in 2007-2008. He now teaches as an Adjunct Professor in the Department of Counseling and Psychological Services at SUNY Oswego.

Dr. Breggin’s work has led to significant changes within the profession. In the early 1970s he conducted an international campaign to stop the resurgence of lobotomy and newer forms of psychosurgery. His reform efforts and his testimony in the Kaimowitz case in Detroit led to the termination of lobotomy and psychosurgery in the nation’s state mental hospitals, NIH, the VA, and most university centers. A public education campaign, including his 1983 medical book, Psychiatric Drugs: Hazards to the Brain, led the FDA to require a new class warning for tardive dyskinesia in 1985. In 1994 his public education campaign led to the NIH to reform some of its research policies and to end the potentially racist violence prevention initiative aimed at inner city children. The FDA’s recent recognition of numerous adverse reactions caused by the newer antidepressants — including suicidality in children and young adults, and a stimulant profile involving agitation, akathisia, hostility, aggression, and mania — closely follows observations made and publicized by Dr. Breggin over the past ten years.

Dr. Breggin's scientific articles can be downloaded on this website. The list can be arranged chronologically or alphebetically. Many of the papers were well ahead of their time, and several helped to influence the FDA to update the required warnings on all labels for antidepressant and antipsychotic medications. All of the articles listed here are available to read without charge on this website."

www.breggin.com

http://www.madinamerica.com/2014/03/neurolpetics-anti-psychotic20-year-follow/

Tuossa on merkittävää tietoa neurolepteistä. Harrow ja Whitaker ovat tehneet hyviä tutkimustuloksia.